Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter

Annals of Neurology

Volumn 74, Issue 4, 2013, Pages 503-505

  Dang, Xin ^a   Koralnik, Igor J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATALIZUMAB;

BRAIN DYSFUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID ANALYSIS; DRUG EXPOSURE; GRANULE CELL NEURONOPATHY; GRAY MATTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOHISTOCHEMISTRY; JC VIRUS; MONOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SYMPTOMATOLOGY; WHITE MATTER;

ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; SPINOCEREBELLAR DEGENERATIONS;

EID: 84890107796     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23985     Document Type: Review

References (27)

1. Schippling S, Kempf C, Büchele F, et al. JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Ann Neurol 2013; 74: 000-000.
2. Richardson EP Jr, Webster HD,. Progressive multifocal leukoencephalopathy: its pathological features. Prog Clin Biol Res 1983; 105: 191-203.
3. Du Pasquier RA, Corey S, Margolin DH, et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 2003; 61: 775-782.
4. Dang X, Koralnik IJ,. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol 2006; 87 (pt 9): 2533-2537.
5. Gheuens S, Wuthrich C, Koralnik IJ,. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol 2013; 8: 189-215.
6. Koralnik IJ, Wuthrich C, Dang X, et al. JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 2005; 57: 576-580.
7. Otis CN, Moral LA,. Images in pathology: granule cell loss in AIDS-associated progressive multifocal leukoencephalopathy. Int J Surg Pathol 2005; 13: 360.
8. Hecht JH, Glenn OA, Wara DW, Wu YW,. JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. Pediatr Neurol 2007; 36: 186-189.
9. Bustamante FG, Cartier RL, Lavados MM,. Cerebellar atrophy by the JC virus in a patient with AIDS. Rev Chil Neuropsiquiatr 2009; 47: 6.
10. Shang T, Delgado A, Adams D,. JC virus granule cell neuronopathy and hyper-IgE in HIV disease. Neurology 2011; 76: 1941-1942.
11. Dang X, Vidal JE, Oliveira AC, et al. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol 2012; 93 (pt 1): 175-183.
12. Piza F, Fink MC, Nogueira GS, et al. JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: clinical presentations, associated factors with mortality and outcome. Braz J Infect Dis 2012; 16: 153-156.
13. Dang L, Dang X, Krans A, et al. JC virus granule cell neuronopathy in a patient treated with rituximab. JAMA Neurol (in press).
14. Shin HW, Kang SY, Sohn YH,. JC viral infection-related cerebellar degeneration as the first manifestation of AIDS. Eur Neurol 2008; 59: 205-207.
15. Granot R, Lawrence R, Barnett M, et al. What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis. J Clin Neurosci 2009; 16: 1091-1092.
16. Tan IL, Brew BJ,. Possible JCV granular cell neuronopathy in a patient with HIV infection. Neurology 2009; 73: 1598-1599.
17. Roux D, Bouldouyre MA, Mercier-Delarue S, et al. JC virus variant associated with cerebellar atrophy in a patient with AIDS. J Clin Microbiol 2011; 49: 2196-2199.
18. Wuthrich C, Cheng YM, Joseph JT, et al. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2009; 68: 15-25.
19. Biogen Idec. PML incidence in patients receiving TYSABRI® (natalizumab). 2013. Available at: http://medinfo.biogenidec.com Accessed July 24, 2013.
20. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab- associated progressive multifocal leukoencephalopathy. N Engl J Med 2012; 366: 1870-1880.
21. Clifford DB, De Luca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010; 9: 438-446.
22. Yin L, Fu SL, Shi GY, et al. Expression and regulation of major histocompatibility complex on neural stem cells and their lineages. Stem Cells Dev 2008; 17: 53-65.
23. Wuthrich C, Dang X, Westmoreland S, et al. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol 2009; 65: 742-748.
24. Dang X, Wuthrich C, Gordon J, et al. JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One 2012; 7: e35793.
25. Martin JB, Banker BQ,. Subacute multifocal leukoencephalopathy with widespread intranuclear inclusions. Arch Neurol 1969; 21: 590-602.
26. Moll NM, Rietsch AM, Ransohoff AJ, et al. Cortical demyelination in PML and MS: similarities and differences. Neurology 2008; 70: 336-343.
27. Lassmann H, Lucchinetti CF,. Cortical demyelination in CNS inflammatory demyelinating diseases. Neurology 2008; 70: 332-333.